Definition of Synchronous Oligometastatic Non–Small Cell Lung Cancer—A Consensus Report

Journal of Thoracic Oncology - Tập 14 Số 12 - Trang 2109-2119 - 2019
Anne‐Marie C. Dingemans1,2,3, Lizza Hendriks2,3, Thierry Berghmans4,5, Antonin Lévy6,7, Baktiar Hasan8, C. Faivre‐Finn9,10, Matteo Giaj Levra11, Niccolò Giaj-Levra12,13, Nicolas Girard14, Laurent Greillier15,16, Sylvie Lantuéjoul17,18, John Edwards19, Mary O’Brien20, Martin Reck21, Egbert F. Smit22, Paul Van Schil23, Pieter E. Postmus24, Sara Ramella25, Yolande Lievens26,27, Mina Gaga28,29, Nir Peled30,31, Giorgio V. Scagliotti32, Suresh Senan33, L. Paz-Ares34, Matthias Gückenberger35,36, Fiona McDonald37, Simon Ekman38, Tanja Čufer39,40, Hester A. Gietema41,3, Maurizio Infante42, Rafał Dziadziuszko43, Solange Peters44, Ramón Rami Porta45,46, Johan Vansteenkiste47, Christophe Dooms47, Dirk De Ruysscher48,3, Benjamin Besse49,7, Silvia Novello32
1Department of Pulmonary diseases, Erasmus Medical Centre, Rotterdam, The Netherlands
2Department of Pulmonary Diseases, Maastricht University Medical Center, Maastricht, the Netherlands
3GROW - School for oncology and developmental biology, University Maastricht, The Netherlands
4Department of Intensive Care and Oncological Emergencies & Thoracic Oncology, Brussels, Belgium
5Jules Bordet Institute, Brussels Free University, Brussels, Belgium
6Department of Radiation Oncology, Gustave Roussy, Thoracic Oncology Institute (IOT), Villejuif, France
7Paris Saclay University, Saint-Aubin, France
8European Organisation for Research and Treatment of Cancer, Brussels, Belgium
9The Christie NHS Foundation Trust, Manchester, United Kingdom
10University of Manchester, Manchester, United Kingdom
11Respiratory Oncology Unit, Department of Thoracic and Vascular disease, Grenoble Alpes University Hospital, Grenoble, France
12Department of Oncology, University of Turin, Torino, Italy
13Department of Radiation Oncology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar-Verona, Italy
14Department of Medical Oncology, Institute Curie, Thorax Institute Curie Montsouris, Paris, France
15Aix Marseille University, Marseille France
16Multidisciplinary Oncology and Therapeutic Innovations, Marseille University Hospital (APHM), Marseille, France
17Department of Biopathology, Centre Léon Bérard UNICANCER, Lyon, France
18Université Grenoble Alpes, INSERM U1209/CNRS 5309 Institute for Advanced Biosciences, Grenoble France
19Department of Cardiothoracic Surgery, Sheffield Teaching Hospitals NHS Foundation Trust, Northern General Hospital, Sheffield, United Kingdom
20Department of Medical Oncology, Royal Marsden Hospital, London, United Kingdom
21Department of Thoracic Oncology, Airway Research Center North, German Center of Lung Diseases, Lung Clinic, Grosshansdorf, Germany
22dept of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands
23Department of Thoracic and Vascular Surgery, Antwerp University Hospital, B-2650 Edegem (Antwerp), Belgium
24Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands
25Radiation Oncology, Campus Bio-Medico University, Rome, Italy
26Ghent University, Ghent, Belgium
27Radiation Oncology Department, Ghent University Hospital, Ghent, Belgium
28European Respiratory Society, Lausanne, Switzerland
29Seventh Respiratory Medicine Dept, Athens Chest Hospital Sotiria, Athens, Greece
30Ben Gurion University, Beer-Sheva, Israel
31The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Cancer Center, Beer-Sheva, Israel
32Oncology Department, University of Turin, AOU San Luigi, Orbassano (TO), Italy
33Radiation Oncology, Cancer Center Amsterdam, Amsterdam UMC, The Netherlands
34Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain
35Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland
36University of Zurich, Zurich, Switzerland
37Department of Radiotherapy, Royal Marsden Hospital, London, United Kingdom
38Thoracic Oncology Center, Karolinska University Hospital/ Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden
39Medical Faculty, University of Ljubljana, Slovenia
40University Clinic Golnik, Ljubljana, Slovenia
41Department of Radiology, Maastricht University Medical Center +, Maastricht, the Netherlands
42Thoracic Surgery Dept. University and Hospital Trust - Ospedale Borgo Trento, Verona, Italy
43Department of Oncology and Radiotherapy, Medical University of Gdansk, 80-211 Gdansk, Poland
44Oncology Department, University Hospital (CHUV), 1011 Lausanne, Switzerland
45Department of Thoracic Surgery, Mútua Terrassa University Hospital, University of Barcelona, Terrassa, Terrassa, Barcelona, Spain
46Network of Centers for Biomedical Research on Respiratory Diseases (CIBERES) Lung Cancer Group, Terrassa, Barcelona, Spain
47Respiratory Oncology Unit, Department of Respiratory Diseases KU Leuven, Leuven, Belgium
48Department of Radiation Oncology, MAASTRO Clinic, Maastricht, The Netherlands
49Department of Cancer Medicine, Gustave Roussy, Villejuif, France

Tóm tắt

Từ khóa


Tài liệu tham khảo

Tanvetyanon, 2008, Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis, J Clin Oncol, 26, 1142, 10.1200/JCO.2007.14.2091

Ashworth, 2014, An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer, Clin Lung Cancer, 15, 346, 10.1016/j.cllc.2014.04.003

Porte, 2001, Resection of adrenal metastases from non-small cell lung cancer: a multicenter study, Ann Thorac Surg, 71, 981, 10.1016/S0003-4975(00)02509-1

Griffioen, 2013, Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors, Lung Cancer, 82, 95, 10.1016/j.lungcan.2013.07.023

Ashworth, 2013, Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature, Lung Cancer, 82, 197, 10.1016/j.lungcan.2013.07.026

Hellman, 1995, Oligometastases, J Clin Oncol, 13, 8, 10.1200/JCO.1995.13.1.8

Weichselbaum, 2011, Oligometastases revisited, Nat Rev Clin Oncol, 8, 378, 10.1038/nrclinonc.2011.44

Novello, 2016, Metastatic non-small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up, Ann Oncol, 27, v1, 10.1093/annonc/mdw326

Planchard, 2018, Metastatic non-small cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up, Ann Oncol, 29, iv192, 10.1093/annonc/mdy275

Eberhardt, 2015, The IASLC Lung Cancer Staging Project: proposals for the revision of the M descriptors in the forthcoming eighth edition of the TNM classification of lung cancer, J Thorac Oncol, 10, 1515, 10.1097/JTO.0000000000000673

De Ruysscher, 2012, Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450), J Thorac Oncol, 7, 1547, 10.1097/JTO.0b013e318262caf6

Bauml, 2017, OA 17.08 Phase II study of pembrolizumab for oligometastatic non-small cell lung cancer (NSCLC) following completion of locally ablative therapy (LAT), J Thorac Oncol, 12, S1794, 10.1016/j.jtho.2017.09.433

Su, 2015, Three-dimensional radiation therapy to the primary tumor with concurrent chemotherapy in patients with stage IV non-small cell lung cancer: results of a multicenter phase 2 study from PPRA-RTOG, China, Int J Radiat Oncol Biol Phys, 93, 769, 10.1016/j.ijrobp.2015.08.012

Gomez, 2016, Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study, Lancet Oncol, 17, 1672, 10.1016/S1470-2045(16)30532-0

Iyengar, 2018, Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial, JAMA Oncol, 4, 10.1001/jamaoncol.2017.3501

Gomez D, Tang C, Zhang J, et al. Local consolidative therapy (LCT) improves overall survival (OS) compared to maintenance therapy/observation in oligometastatic non-small cell lung cancer (NSCLC): final results of a multicenter, randomized, controlled phase 2 trial. Abstract presented at: 2018 Annual Meeting of the American Socity for Radiation Oncology. October 21–24, 2018; San Antonio, TX.

Levy, 2018, MA25.01. EORTC Lung Cancer Group survey to define synchronous oligometastatic disease in NSCLC [abstract], J Thorac Oncol, 13, S445, 10.1016/j.jtho.2018.08.529

GiajLevra

Dooms C, De Leyn P, Deroose C, et al. P3.09-004 - Oligometastatic non-small cell lung cancer: a simulation expert multidisciplinary tumor board. Paper presented at: 15th World Conference on Lung Cancer. October 27–30, 2018; Sydney, Australia.

Hendriks, 2018, MA25.03. Defining oligometastatic non-small cell lung cancer (NSCLC): an evolving multidisciplinary expert opinion [abstract], J Thorac Oncol, 13, S446, 10.1016/j.jtho.2018.08.531

deSouza, 2018, Strategies and technical challenges for imaging oligometastatic disease: recommendations from the European Organisation for Research and Treatment of Cancer imaging group, Eur J Cancer, 91, 153, 10.1016/j.ejca.2017.12.012

De Leyn, 2014, Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer, Eur J Cardiothorac Surg, 45, 787, 10.1093/ejcts/ezu028

Hendriks, 2015, Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: results from a population-based study, Eur J Cancer, 51, 2534, 10.1016/j.ejca.2015.08.008

Goldstraw, 2016, The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer, J Thorac Oncol, 11, 39, 10.1016/j.jtho.2015.09.009

De Ruysscher, 2018, Progression-free-survival and overall survival beyond 5 years of non-small cell lung cancer patients with synchronous oligometastases treated in a prospective phase II trial (NCT 01282450), J Thorac Oncol, 13, 1958, 10.1016/j.jtho.2018.07.098

Conibear, 2018, Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer, BMJ Open, 8, 10.1136/bmjopen-2017-020690

Postmus, 2017, Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up, Ann Oncol, 28, iv1, 10.1093/annonc/mdx222

Thông tin
Thông tin xuất bản

Journal of Thoracic Oncology

Tập 14 Số 12

2109-2119

Thông tin tác giả